NAAG sent a letter to the Food and Drug Administration (FDA) in response to their request for comments regarding “Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds.”
Lead States
District of Columbia, Oklahoma
Signatory States
AK, AL, CA, CO, CT, DC, DE, GU, HI, IA, ID, IL, KY, LA, MA, MD, ME, MI, MN, MP, MS, MT, NC, ND, NE, NJ, NM, NY, OH, OK, OR, PA, RI, TN, VA, VT, WA
